Engineered for the CRISPR Community
10 years of CRISPR technology! That’s right, World CRISPR Day 2022 is a big one. From basic research to real-world applications, we’re recognizing a whole decade of CRISPR and the positive impact this technology is making across the globe.
Get up-to-date with the latest research and breakthroughs. We know the field is moving rapidly, and it can be hard to stay on top of all the incredible CRISPR developments out there. World CRISPR Day is the perfect opportunity to keep your finger on the community pulse.
After all, it was a chance meeting after a conference that led to Doudna and Charpentier’s groundbreaking CRISPR paper! While we aren't in-person (yet), use this excellent chance to connect with speakers, learn about opportunities, and inspire new methods of collaboration.
Chief Scientific Officer
Intellia Therapeutics
Chief Scientific Officer
Excision BioTherapeutics
Assistant Professor
Arizona State University
Leader, Genome Editing Program
National Institute of Standards and Technology
Professor
Augusta University
Assistant Professor
Columbia University
Assistant Professor
University College London
Assistant Professor
Arc Institute & UC Berkeley
Co-Founder & CEO
Synthego
McGovern Fellow
MIT
McGovern Fellow
MIT
Vice President, R&D Gene Editing
AskBio
Executive Editor
The CRISPR Journal
Director, Technical Support & Customer Success
Synthego
M.D. Ph.D. Student
UC San Diego School of Medicine
Director, Operations Engineering
Synthego
Associate Professor
University College London
Charite Berlin Medical University
Associate Director, Clinical Marketing
Synthego
Genome Editing Leader
BioHeuris
Director
UCSF Quantitative Biosciences Institute (QBI)
Chief Operating Officer
UCSF Quantitative Biosciences Institute
Andalusian Center for Development Biology
VP, PMO & Business Systems
Synthego
Associate Professor
Aarhus University
Postdoctoral Researcher
ETH Zürich
Genome Editor
Innovative Genomics Institute & UC Berkeley
Senior Research Associate
University College London
Director, Cell and Gene Therapy
Synthego
Mechanical Engineer
Synthego
Director of Applied Research and Innovation
Synthego
Head of Science
Synthego
It features an all-star cast of scientists from around the world focused on utilizing CRISPR to generate gene and cell therapies, accelerate discovery biology and drug discovery, and imagine new gene editing innovations.
Session 1
Thu 9:00 - 11:10 AM
Session 2
Thu 11:25 - 1:05 PM
Session 3
Thu 1:25 - 4:05 PM
In the 10 years since CRISPR was developed, scientists have massively expanded and improved the genome engineering toolbox. There are now a wide range of technologies derived from the original CRISPR-Cas9 system that can be used for different applications, new nucleases that have been discovered and engineered, and a variety of methods to improve CRISPR editing efficiencies.
In this session, we’ve lined up some of the key pioneers of CRISPR technology to present their latest innovations and improvements, including next-generation gene editing techniques such as base editing, recombinases, and PASTE, increasing homology directed repair to improve editing outcomes, overcoming the challenges of CRISPR editing in primary cells, and new delivery strategies.
9:00 AM
Kevin Holden, Ph.D.
9:05 AM
Paul Dabrowski
9:15 AM
Montse Morell, Ph.D.Brandon Whitney
9:20 AM
Eric Aird, Ph.D.
9:35 AM
Audronė Lapinaitė, Ph.D.
9:50 AM
Ting Zheng, Ph.D.
10:05 AM
Giando Turchiano, Ph.D.
10:20 AM
Srishti Sahu
10:35 AM
Patrick Hsu, Ph.D.
10:50 AM
Omar Abudayyeh, Ph.D.Jonathan Gootenberg, Ph.D.